Professor Danny McAuley from the Centre for Infection and Immunity, a partner in developing the new nanomedicine, said that, if successful, this nanomedicine could also have application in other common lung disorders such as Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis.

BBC: lungs